Article Information
vol. 4 no. 36
- Received November 8, 2017
- Revision received February 1, 2019
- Accepted May 20, 2019
- .
Author Information
- Mariaelvy Bianchini1,*,
- Johan Duchêne1,*,†,
- Donato Santovito1,
- Maximilian J. Schloss1,
- Maximilien Evrard2,3,
- Holger Winkels1,
- Maria Aslani1,
- Sarajo K. Mohanta1,
- Michael Horckmans1,
- Xavier Blanchet1,
- Michael Lacy1,
- Philipp von Hundelshausen1,4,
- Dorothee Atzler1,4,5,
- Andreas Habenicht1,
- Norbert Gerdes6,
- Jaroslav Pelisek7,
- Lai Guan Ng2,3,
- Sabine Steffens1,4,
- Christian Weber1,8,*,† and
- Remco T. A. Megens1,8,*
- 1Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU), 80336 Munich, Germany.
- 2Singapore Immunology Network (SIgN), A*STAR (Agency for Science, Technology and Research), Biopolis, 138648 Singapore.
- 3School of Biological Sciences, Nanyang Technological University, 637551 Singapore.
- 4German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, 80336 Munich, Germany.
- 5Walther Straub Institute of Pharmacology and Toxicology, University of Munich, 80336 Munich, Germany.
- 6Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.
- 7Department of Vascular and Endovascular Surgery, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
- 8Cardiovascular Research Institute Maastricht, University of Maastricht, 6229 ER, Maastricht, Netherlands.
- ↵†Corresponding author. Email: jduchen{at}med.lmu.de (J.D.); chweber{at}med.lmu.de (C.W.)